With the race to find a vaccine for the cure of novel coronavirus, six candidates from around the world are now at stage three of human trials. According to recent reports, one candidate from Russia has claimed to have completed all the three stages of human clinical assessment, fortunately. Russia will soon start the production of the vaccine to be distributed massively worldwide. The Health Ministry of Russia has confirmed that the first COVID-19 vaccine will be registered after one week of its launch.
Currently, Russia has two vaccine candidates in the race for the development of the COVID-19 vaccine. One is a vaccine being produced by The Vektor State Research Center of Virology and Biotechnology. The other one is being developed by Gamaleya Scientific Research Institute of Epidemiology and Microbiology which is working along with the Russian Defence Ministry. The vaccine developed by the Gamaleya institute has been approved and proper clinical trials have been done. It is believed to be made available within three to seven days of registration.
According to Alexander Gintsburg, the director of the Gamaleya Research Institute situated in Moscow the vaccine consists of inanimate particles that are developed on the basis of adenovirus. The researchers who have been involved with the development of the vaccine have tried it on themselves first.
The industrial production of the vaccine is likely to begin by September and will be made available to the masses across the country by the end of October. The Russian companies have made a deal to produce several thousands of doses by the end of this year. As of now, there is no concern about the vaccine causing any potential harm to anyone. Individuals might develop a mild fever as the immune system will be vaccinated by a powerful boost but this can be easily cured by taking paracetamol.
The World Health Organisation has been keeping a check on the success of different coronavirus vaccine candidates, but till now has not made any reference to the vaccine clearing all the three stages. Some of the health experts might be worried that Russia is trying to fast forward the vaccine development process which might put people at risk. WHO has asked the developers to follow properly established guidelines for the production of a safe and effective vaccine. According to Christian Lindmeier, the spokesman at WHO, researchers claim that they have discovered something, which is a great release. But having found something and actually developing a vaccine that works are two different things.
Russia is also expected to develop 26 additional coronavirus vaccines at other seventeen research institutions. Within a span of six to eight weeks, two vaccines out of the list will also start clinical trials on volunteers.